FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1843286004> ?p ?o ?g. }

• W1843286004 endingPage "471" @default.
• W1843286004 startingPage "465" @default.
• W1843286004 abstract "Epilepsy, which is present in 0.5–1% of the paediatric population, is one of the most frequent childhood neurological disorders. Approximately 20% to 30% of these cases will be drug-resistant. The objective of this study is to describe the impact of vagal nerve stimulation (VNS) on seizures and quality of life in a sample of 30 patients. Descriptive, retrospective study of all patients with a VNS device implanted between 2008 and 2013 in a single paediatric hospital, based on patients’ medical records. Quality of life was assessed using the Spanish scale for quality of life in children with epilepsy, completed by means of a telephone interview. We describe a population of 19 boys (64%) and 11 girls (36%) with a mean age at seizure onset of 21 months (1–144 months). The mean age of VNS implantation was 11.89 years. Follow-up periods ranged from 6 to 36 months. Mean reduction in seizures at 6 months was 38%, with a reduction of 43% at 12 months, 42% at 24 months, and 54% at 36 months. At least half of all patients were classified as responders. According to the quality of life scale, 54% of the families rated the effect of VNS as either very good or good while 39% rated it as fair. VNS is a safe palliative treatment that is generally well tolerated. It is partially effective for controlling drug-resistant epilepsy and exerts a positive effect on quality of life. La epilepsia es uno de los trastornos neurológicos más frecuentes de la infancia, presentándose en un 0,5–1%. Aproximadamente un 20–30% de los pacientes son farmacorresistentes. El objetivo de este trabajo es describir en 30 pacientes el impacto sobre las crisis y la calidad de vida del estimulador del nervio vago (ENV). Se trata de un estudio descriptivo, retrospectivo, mediante revisión de las historias clínicas de todos los pacientes a quienes se les colocó el ENV entre el 2008 y 2013 en nuestro centro. La calidad de vida fue valorada mediante la escala de calidad de vida en el niño con epilepsia (CAVE), obtenida por medio de una entrevista telefónica. Se incluyeron 19 niños (64%) y 11 niñas (36%) con una mediana de comienzo de las crisis de 21 meses (1–144 meses). La edad promedio de colocación del ENV fue de 11,89 años. El tiempo de seguimiento fue de 6–36 meses. A los 6 meses la reducción de las crisis en promedio fue del 38%, a los 12 meses del 43%, a los 24 meses del 42% y a los 36 meses del 54%. De todos los pacientes evaluados al menos un 50% se catalogaron como respondedores. Según la CAVE un 54% de las familias encontró el efecto del ENV como bueno o muy bueno y un 39% como regular. El ENV es un tratamiento paliativo, generalmente bien tolerado, parcialmente efectivo para el control de la epilepsia refractaria en pediatría y con repercusiones positivas sobre la calidad de vida." @default.
• W1843286004 created "2016-06-24" @default.
• W1843286004 creator A5006715304 @default.
• W1843286004 creator A5014568024 @default.
• W1843286004 creator A5023571511 @default.
• W1843286004 creator A5033200537 @default.
• W1843286004 creator A5041904619 @default.
• W1843286004 creator A5043678797 @default.
• W1843286004 creator A5049769691 @default.
• W1843286004 creator A5075740862 @default.
• W1843286004 creator A5076182991 @default.
• W1843286004 creator A5080683540 @default.
• W1843286004 creator A5087559969 @default.
• W1843286004 date "2015-10-01" @default.
• W1843286004 modified "2023-09-27" @default.
• W1843286004 title "Vagus nerve stimulator implantation for epilepsy in a paediatric hospital: outcomes and effect on quality of life" @default.
• W1843286004 cites W1509856631 @default.
• W1843286004 cites W1589660062 @default.
• W1843286004 cites W1912685757 @default.
• W1843286004 cites W193707109 @default.
• W1843286004 cites W1999022180 @default.
• W1843286004 cites W2023143313 @default.
• W1843286004 cites W2052410856 @default.
• W1843286004 cites W2056338994 @default.
• W1843286004 cites W2067243515 @default.
• W1843286004 cites W2081912198 @default.
• W1843286004 cites W2096398163 @default.
• W1843286004 cites W2101808151 @default.
• W1843286004 cites W2116439734 @default.
• W1843286004 cites W2153830231 @default.
• W1843286004 doi "https://doi.org/10.1016/j.nrleng.2015.08.007" @default.
• W1843286004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24975345" @default.
• W1843286004 hasPublicationYear "2015" @default.
• W1843286004 type Work @default.
• W1843286004 sameAs 1843286004 @default.
• W1843286004 citedByCount "7" @default.
• W1843286004 countsByYear W18432860042017 @default.
• W1843286004 countsByYear W18432860042019 @default.
• W1843286004 countsByYear W18432860042023 @default.
• W1843286004 crossrefType "journal-article" @default.
• W1843286004 hasAuthorship W1843286004A5006715304 @default.
• W1843286004 hasAuthorship W1843286004A5014568024 @default.
• W1843286004 hasAuthorship W1843286004A5023571511 @default.
• W1843286004 hasAuthorship W1843286004A5033200537 @default.
• W1843286004 hasAuthorship W1843286004A5041904619 @default.
• W1843286004 hasAuthorship W1843286004A5043678797 @default.
• W1843286004 hasAuthorship W1843286004A5049769691 @default.
• W1843286004 hasAuthorship W1843286004A5075740862 @default.
• W1843286004 hasAuthorship W1843286004A5076182991 @default.
• W1843286004 hasAuthorship W1843286004A5080683540 @default.
• W1843286004 hasAuthorship W1843286004A5087559969 @default.
• W1843286004 hasBestOaLocation W18432860041 @default.
• W1843286004 hasConcept C118552586 @default.
• W1843286004 hasConcept C126322002 @default.
• W1843286004 hasConcept C159110408 @default.
• W1843286004 hasConcept C24998067 @default.
• W1843286004 hasConcept C2778186239 @default.
• W1843286004 hasConcept C2779951463 @default.
• W1843286004 hasConcept C2780087125 @default.
• W1843286004 hasConcept C2781404750 @default.
• W1843286004 hasConcept C42219234 @default.
• W1843286004 hasConcept C71924100 @default.
• W1843286004 hasConceptScore W1843286004C118552586 @default.
• W1843286004 hasConceptScore W1843286004C126322002 @default.
• W1843286004 hasConceptScore W1843286004C159110408 @default.
• W1843286004 hasConceptScore W1843286004C24998067 @default.
• W1843286004 hasConceptScore W1843286004C2778186239 @default.
• W1843286004 hasConceptScore W1843286004C2779951463 @default.
• W1843286004 hasConceptScore W1843286004C2780087125 @default.
• W1843286004 hasConceptScore W1843286004C2781404750 @default.
• W1843286004 hasConceptScore W1843286004C42219234 @default.
• W1843286004 hasConceptScore W1843286004C71924100 @default.
• W1843286004 hasIssue "8" @default.
• W1843286004 hasLocation W18432860041 @default.
• W1843286004 hasLocation W18432860042 @default.
• W1843286004 hasOpenAccess W1843286004 @default.
• W1843286004 hasPrimaryLocation W18432860041 @default.
• W1843286004 hasRelatedWork W2051211818 @default.
• W1843286004 hasRelatedWork W2062415294 @default.
• W1843286004 hasRelatedWork W2330088021 @default.
• W1843286004 hasRelatedWork W2347513722 @default.
• W1843286004 hasRelatedWork W2351134641 @default.
• W1843286004 hasRelatedWork W2894977198 @default.
• W1843286004 hasRelatedWork W3010486731 @default.
• W1843286004 hasRelatedWork W3030551708 @default.
• W1843286004 hasRelatedWork W4286380861 @default.
• W1843286004 hasRelatedWork W4309656954 @default.
• W1843286004 hasVolume "30" @default.
• W1843286004 isParatext "false" @default.
• W1843286004 isRetracted "false" @default.
• W1843286004 magId "1843286004" @default.
• W1843286004 workType "article" @default.